[Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
Schnider
P
P
Voller
B
B
Moraru
K
K
Auff
E
E
D018726:Anti-Dyskinesia Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001764:Blepharospasm / Q000188:drug therapy; D001905:Botulinum Toxins / Q000494:pharmacology* / Q000627:therapeutic use*; D020821:Dystonic Disorders / Q000188:drug therapy*; D004931:Esophageal Achalasia / Q000188:drug therapy; D006801:Humans; D007273:Injections, Intramuscular; D009069:Movement Disorders / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy*; D014832:Voice Disorders / Q000188:drug therapy
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins
Die Botulinumtoxinbehandlung: Vom gefürchteten biologischen Toxin zum Standardmedikament.